Form 4 Filing for Camp4 Therapeutics Corp

This Form 4 filing details a transaction by Gold Kelly, the Chief Financial Officer of Camp4 Therapeutics Corp. On August 3, 2026, Kelly acquired 6,551 shares of common stock through a private placement at a purchase price of $1.65 per share. This acquisition was part of the second closing of a private placement initiated by a Securities Purchase Agreement dated September 9, 2025, and amended on August 3, 2026. The transaction involved the issuer and certain institutional investors, directors, employees, and consultants. Following this transaction, Kelly holds 74,428 shares of common stock, with the ownership nature indicated as direct.